ABL, a synthetic parathyroid hormone–related peptide (PTHrP) analog with amino acid substitutions between positions 22 and 31 of PTHrP(1–34), is an alternative anabolic therapy for postmenopausal women with osteoporosis [17, 18]. The gene discussed is PTHLH; the disease is osteoporosis.